- Home
- OCS vs STGW Comparison
OCS vs STGW Comparison
Compare OCS & STGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- STGW
- Stock Information
- Founded
- OCS 2003
- STGW 1980
- Country
- OCS Switzerland
- STGW United States
- Employees
- OCS N/A
- STGW N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- STGW
- Sector
- OCS Health Care
- STGW
- Exchange
- OCS Nasdaq
- STGW Nasdaq
- Market Cap
- OCS 717.3M
- STGW 814.3M
- IPO Year
- OCS N/A
- STGW N/A
- Fundamental
- Price
- OCS $17.31
- STGW $7.29
- Analyst Decision
- OCS Strong Buy
- STGW Strong Buy
- Analyst Count
- OCS 5
- STGW 5
- Target Price
- OCS $29.20
- STGW $8.50
- AVG Volume (30 Days)
- OCS 39.4K
- STGW 422.1K
- Earning Date
- OCS 11-07-2024
- STGW 11-07-2024
- Dividend Yield
- OCS N/A
- STGW N/A
- EPS Growth
- OCS N/A
- STGW N/A
- EPS
- OCS N/A
- STGW 0.00
- Revenue
- OCS $1,027,571.00
- STGW $2,707,403,000.00
- Revenue This Year
- OCS $6.87
- STGW $13.05
- Revenue Next Year
- OCS $884.16
- STGW N/A
- P/E Ratio
- OCS N/A
- STGW $2,578.43
- Revenue Growth
- OCS N/A
- STGW 4.92
- 52 Week Low
- OCS $10.11
- STGW $4.88
- 52 Week High
- OCS $18.00
- STGW $8.18
- Technical
- Relative Strength Index (RSI)
- OCS 68.45
- STGW 41.25
- Support Level
- OCS $15.45
- STGW $7.01
- Resistance Level
- OCS $17.92
- STGW $7.66
- Average True Range (ATR)
- OCS 0.50
- STGW 0.24
- MACD
- OCS 0.17
- STGW -0.11
- Stochastic Oscillator
- OCS 81.42
- STGW 15.38
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About STGW Stagwell Inc.
Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; Communications Network and other. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.